Research Use Only - Not for human consumption. 18+ only.
Clinical TrialsKhavinson BioregulatorsSubcutaneous

Vesugen

Vascular bioregulator peptide from the Khavinson series. Short peptide (2-4 amino acids) that targets specific tissue for gene expression regulation and organ health optimization.

Research Status

Clinical Trials

Limited Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Supports vascular endothelial function
Promotes healthy blood vessel integrity
May enhance tissue-specific gene expression
Supports cardiovascular tissue health
Aids in organ-specific bioregulation

Side Effects

Local injection site reactions
UncommonMild

Mild redness, warmth, or slight swelling at injection site. Typically resolves within 1-2 hours. Rotate injection sites to minimize occurrence. Apply ice if needed.

Mild headache
UncommonMild

Occasional headache reported in early treatment phase. Usually resolves within 24-48 hours. Ensure adequate hydration.

Transient flushing
RareMild

Brief facial flushing or warmth may occur shortly after injection. Self-resolving within minutes to hours.

Mild dizziness
RareMild

Occasional lightheadedness reported. Sit or lie down if experienced. Typically resolves quickly.

Allergic reaction
RareSerious

Seek immediate medical attention if experiencing rash, difficulty breathing, swelling of face/throat, or severe itching. Discontinue use immediately.

Dosing Reference

ParameterValue
Dose range10-20 mcg
Frequency1x daily
TimingMorning, sublingual or subcutaneous
RouteSubcutaneous

Khavinson bioregulator peptide. Limited Western clinical data; primarily studied in Russian and Eastern European research. Start at lower end (10 mcg) and assess response before titrating. For research purposes only.

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline — use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2–8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Vesugen is a short-chain peptide bioregulator from the Khavinson series designed to support vascular endothelial function and tissue-specific gene expression. It acts as a tissue-selective regulator that may enhance the expression of genes involved in vascular integrity, angiogenesis, and cardiovascular homeostasis. The peptide is thought to work through receptor-mediated signaling pathways that promote healthy blood vessel structure and function.

Vascular Endothelial Growth Factor (VEGF) Signaling

May enhance endothelial cell survival and promote angiogenesis through modulation of VEGF-related pathways, supporting healthy blood vessel formation and maintenance.

Tissue-Specific Gene Expression

Acts as a bioregulator to selectively enhance expression of genes involved in vascular function, endothelial integrity, and cardiovascular homeostasis.

Endothelial Nitric Oxide Synthase (eNOS) Activity

May support nitric oxide production in endothelial cells, promoting vasodilation and healthy blood flow regulation.

  • Vesugen is part of the Khavinson peptide bioregulator family, which targets specific tissues for organ-level health optimization
  • Short peptide structure (2-4 amino acids) allows for tissue-selective uptake and bioregulatory action
  • Mechanism involves gene expression regulation rather than direct enzymatic activity
  • Research primarily conducted in Russian and Eastern European clinical settings; limited Western peer-reviewed data available
  • Bioregulator peptides are thought to work through receptor-mediated signaling that restores age-related declines in tissue function

Track your Vesugen research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Vesugen is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.